TAGC sponsors 2023 MDHS Honours Conference
TAGC was proud to sponsor the University of Melbourne’s annual MDHS Honours Conference this year, in line with the partnership’s commitment to supporting scholarship and learning opportunities to equip the next generation of researchers with the skills to lead the genomic workforce of the future.
Evolving through learning | Internship case study
Master of Epidemiology student Phoebe Yu wanted to learn more about the latest innovations in genomics research. An internship with Illumina gave her new experience in marketing and strengthened her analytical skills.
Making advanced genomic testing more accessible for cancer patients
The TAGC team recently received full diagnostic accreditation through the National Association of Testing Authorities (NATA) to perform ‘ctDNA profiling’ analysing tumour DNA collected via liquid biopsy. It’s a crucial step towards making advanced genomics testing more affordable and accessible.
Understanding the business of science | Genomics internship case study
Robiel Abraham was undertaking a Bachelor of Science, majoring in neuroscience, when he did a two-month internship with Illumina in early 2022. "This internship provided me with experience of working in a more autonomous professional environment, which was really eye opening."
A clearer vision for the future | Genomics internship case study
Greta Medawar is a second-year Master of Biotechnology student at the University of Melbourne. She undertook a six-week internship with Illumina's ANZ marketing team, mapping out the landscape of Next-Generation Sequencing (NGS)-based cancer research in the region.
Call for commercially viable genomics projects
Genomics projects with a demonstrable commercial focus are invited to apply for up to $2 million in funding from The Advanced Genomics Collaboration (TAGC). To be eligible, applicants must be based at The University of Melbourne and MACH partner organisations.
ID Predict: A genomics-focused platform for treatment of COVID-19 and other infectious diseases
Genomics platform to understand the varied types of disease progression of patients with COVID-19, which will help to identify what treatment is best suited to individual patients.
Genomics innovation hub to drive research and clinical impact
The University of Melbourne, together with international genomics company, Illumina, have welcomed the Victorian Government’s support to establish a $60 million world-leading genomics hub in Victoria.